IQVIA, a global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, appointed Richard Staub, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions (R&DS) business unit.

Staub has 34 years of experience in the life science sector and has held numerous senior executive roles across multiple contract research organizations. He previously served as the president of the R&DS business unit at IQVIA from 2016 to 2022. Under his leadership the R&DS business unit accelerated its growth, recorded consecutive years of record-breaking backlog, posted industry leading book to bill ratios and significantly increased R&DS revenues.

During his tenure Staub oversaw the rapid expansion of IQVIA’s clinical research capabilities and he successfully led this business unit through the unprecedented challenges of the COVID-19 global pandemic.

In his role as senior advisor to the Chairman and CEO of IQVIA, Staub worked closely with the R&DS team and was instrumental in R&DS’ continued success. He had responsibility for key customer relationships, provided leadership on critical business issues and continued to guide the overall strategic direction of the business.